Australia markets closed

AVITA Medical, Inc. (AVH.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
4.7200-0.0100 (-0.21%)
At close: 4:10PM AEDT
Full screen
Previous close4.7300
Open4.7400
Bid4.7200 x 734600
Ask4.7400 x 258500
Day's range4.6900 - 4.7600
52-week range4.4000 - 7.4000
Volume97,856
Avg. volume323,251
Market cap587.541M
Beta (5Y monthly)0.29
PE ratio (TTM)N/A
EPS (TTM)-0.3180
Earnings date29 Apr 2020
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est10.21
  • GlobeNewswire

    AVITA Medical to Present at the 2021 Cantor Virtual Global Healthcare Conference

    VALENCIA, Calif., and MELBOURNE, Australia, Sept. 13, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that its management will present at the 2021 Cantor Virtual Global Healthcare Conference on Monday, September 27, 2021 at 4:00 p.m. Eastern Daylight Time / Tuesday, September 28, 2021 a

  • GlobeNewswire

    AVITA Medical to Participate at the Lake Street 2021 BIG5 Conference

    VALENCIA, Calif., and MELBOURNE, Australia, Aug. 31, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that its management will participate at the Lake Street 2021 BIG5 Conference on Tuesday, September 14, 2021. Authorized for release by the Chief Financial Officer of AVITA Medical, Inc.

  • GlobeNewswire

    AVITA Medical Reports Fourth Quarter and Fiscal Year 2021 Financial Results

    VALENCIA, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX:AVH) (Company), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, today reported financial results for its fourth quarter of fiscal year 2021, ended June 30, 2021. Fourth Quarter of Fiscal Year 2021 Highlights Total net revenue increased 166% to $10.3 million compared to $3.9 million